论文部分内容阅读
上海联合基因科技集团下属博德基因开发有限公司一项题为“基于基因芯片的抗肿瘤药物筛选模型”研究，于近期通过上海市科委组织的成果鉴定。刘新垣、陈凯先院士等专家认为，该项研究成功地将基因数据库和基因芯片技术运用于新的抗肿瘤药物筛选，使中国新药筛选技术进入国际先
Shanghai United Gene Technology Group under the Bode Gene Development Co., Ltd. a “gene chip-based anti-cancer drug screening model” research, recently organized by Shanghai Science and Technology Commission to identify the results. Liu Xinyuan, Academician Chen Kai Xian and other experts believe that the research successfully applied genetic database and gene chip technology to new anti-tumor drug screening, making Chinese drug screening technology enter the world first